ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Teva Pharmaceuticals USA, INC.

Official 2024 U.S. DOL Form 5500 summary for Teva Pharmaceuticals USA, INC. (Teva Pharmaceuticals Retirement Savings Plan · EIN 22-1734359 · PN 004): $2.33B net assets, 5,037 active participants, and $4.04 per $10,000 (4.04 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorTeva Pharmaceuticals USA, INC.
Filing IdentifierTeva Pharmaceuticals Retirement Savings Plan · EIN 22-1734359 · PN 004
Plan Category & State401(k) Defined Contribution (NJ)
Asset-Size Peer Cohort>$1B
Plan Net Assets (2024)$2.33B
Active Participants5,037
Direct Admin Fee Rate$4.04 per $10,000 (4.04 bps)
Cohort Peer Median$4.40 per $10,000 (4.40 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI

Cross-Agency Entity Graph

Related Filings Across Meru Platforms

Verified federal filings reconciled for Teva Pharmaceuticals across sibling Meru AI platforms.